心臓ポンプ装置市場は、2021年の21億ドルから2026年までに55億ドルに達し、2021年から2026年までのCAGRは21.6％と予想されます。予測期間中は、心不全治療に関する研究への投資、資金、助成金の増加、心血管疾患の有病率の上昇、心臓移植の長い待機期間、心臓ポンプ装置に対する有利な医療制度、肥満の増加が市場の成長要因になります。
世界的なCOVID-19の感染拡大後、ヘルスケアセクターは大きく変化しています。心臓治療の部門では、ウイルスへの曝露のリスクを抑えるために、さまざまな国が待機的手術の延期を決定しました。集中治療リソースの再配分と、定量化が不可能なCOVID-19への感染リスクのため、英国では医療制度に課される負担に対処するため、選択的心臓手術が延期されました。
2020年2月21日から3月31日までイタリアの8つの病院で実施された調査によると、ロックダウン中に血液ろ過（HF）のための入院件数が大幅に減少したことが明らかになりました。実際、HF患者の一部はCOVID-19によるロックダウン中に医師の診察を受けずに自宅で死亡した可能性があります。HFに関連した入院が減少したため、心臓ポンプ装置の市場は2020年に大幅に減少しました。
同様に、この市場で事業に従事している企業も、COVID-19の発生によって収益が減少しています。例えばAbiomedの年次報告書によると、2020年度の第4四半期には患者の診察が減り、患者の利用率が低かったため、Impella製品の売上が減少しました。COVID-19は、主に米国とヨーロッパで、Impella製品の売上に約1,700万ドルの悪影響を及ぼしました。
COVIDの発生により、FDAは、肺塞栓症（PE）を含む右心不全または代償障害のCOVID患者を治療するための心臓補助装置を製造している企業に緊急使用許可（EUA）を付与しました。2020年8月、アビオメッドは、左心室除荷を提供し、ECMO治療を受けているCOVID-19患者をサポートするために、左側のインペラ心臓ポンプについてFDAから緊急使用許可（EUA）を付与されました。同社は、COVID-19関連の右心不全や代償障害に苦しむ患者も含めて、FDAからインペラRPについて緊急使用許可を受けました。これらの開発は、会社の大幅な成長に寄与しました。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 HEART PUMP DEVICES: MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 31)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 APPROACH 3: PARENT MARKET ANALYSIS [ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET]
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19 ECONOMIC ASSESSMENT
2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 10 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 12 HEART PUMP DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
FIGURE 13 HEART PUMP DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
FIGURE 14 HEART PUMP DEVICES MARKET, BY THERAPY, 2021 VS. 2026 (USD BILLION)
FIGURE 15 HEART PUMP DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD BILLION)
4 PREMIUM INSIGHTS (Page No. - 47)
4.1 HEART PUMP DEVICES MARKET OVERVIEW
FIGURE 16 THE RISING INCIDENCE OF HEART FAILURE IS A MAJOR FACTOR DRIVING THE GROWTH OF THE HEART PUMP DEVICES MARKET
4.2 EUROPE: HEART PUMP DEVICES MARKET SHARE, BY THERAPY (2020)
FIGURE 17 BTT THERAPY SEGMENT DOMINATED THE EUROPEAN MARKET IN 2020
4.3 GEOGRAPHICAL SNAPSHOT OF THE HEART PUMP DEVICES MARKET
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 50)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 HEART PUMP DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing investments, funds, and grants for research on heart failure treatment
5.2.1.2 Rising prevalence of cardiovascular diseases
FIGURE 20 SHARE OF GLOBAL POPULATION AGED 65 AND ABOVE (2015-2019)
5.2.1.3 Long waiting periods for heart transplant procedures
5.2.1.4 Favorable reimbursements for heart pump devices
TABLE 1 CPT CODES FOR PROCEDURES RELATED TO VENTRICULAR ASSIST DEVICES AND TAH
TABLE 2 CPT CODES FOR PROCEDURES RELATED TO IABP
5.2.1.5 Increasing prevalence of obesity
5.2.2 RESTRAINTS
5.2.2.1 Complications associated with LVAD implantations
5.2.2.2 Lack of funding for destination therapy
5.2.3 OPPORTUNITIES
5.2.3.1 Promising product pipeline
TABLE 3 TOTAL ARTIFICIAL HEARTS IN PIPELINE
5.2.3.2 Increasing number of product approvals
TABLE 4 RECENT APPROVALS IN THE HEART PUMP DEVICES MARKET, 2018-2020
5.2.3.3 Emerging markets
5.2.4 CHALLENGES
5.2.4.1 Frequent product recalls
TABLE 5 KEY PRODUCT RECALLS IN THE HEART PUMP DEVICES MARKET
5.2.4.2 Stringent regulatory requirements delaying the approval of cardiac devices
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 21 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY OF PROMINENT COMPANIES
5.4 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.5 ECOSYSTEM ANALYSIS
FIGURE 23 ECOSYSTEM ANALYSIS OF THE HEART PUMP DEVICES INDUSTRY
5.5.1 ROLE IN THE ECOSYSTEM
5.6 REGULATORY LANDSCAPE
TABLE 6 LIST OF REGULATORY AUTHORITIES
5.6.1 EU REGULATIONS
5.6.2 US REGULATIONS
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT FROM NEW ENTRANTS
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 INTENSITY OF COMPETITIVE RIVALRY
5.7.5 THREAT FROM SUBSTITUTES
5.8 COVID-19 IMPACT ANALYSIS FOR THE HEART PUMP DEVICES MARKET
FIGURE 24 PERCENTAGE OF MEDTRONIC’S CARDIAC AND VASCULAR GROUP NET SALES, BY DIVISION, FY 2019 VS. FY 2020
5.9 PATENT ANALYSIS
5.9.1 VENTRICULAR ASSIST DEVICES
5.9.2 TOTAL ARTIFICIAL HEARTS
5.9.3 INTRA-AORTIC BALLOON PUMPS
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA, BY COUNTRY, 2017-2019 (USD MILLION)
5.10.2 EXPORT DATA, BY COUNTRY, 2017-2019 (USD MILLION)
5.10.3 EXPORT DATA, BY COUNTRY, 2017-2019 (KILOGRAMS)
5.10.4 IMPORT DATA, BY COUNTRY, 2017-2019 (KILOGRAMS)
5.11 TECHNOLOGY ANALYSIS
5.12 AVERAGE SELLING PRICE TREND
TABLE 7 AVERAGE SELLING PRICES OF HEART PUMP DEVICE PRODUCTS
5.13 YCC SHIFT
6 HEART PUMP DEVICES MARKET, BY PRODUCT (Page No. - 73)
6.1 INTRODUCTION
TABLE 8 HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
6.2 VENTRICULAR ASSIST DEVICES
TABLE 9 VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 10 VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
6.2.1 LEFT VENTRICULAR ASSIST DEVICES
6.2.1.1 LVADs are the most common types of VAD used—a key factor driving market growth
TABLE 11 LEFT VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
6.2.2 PERCUTANEOUS VENTRICULAR ASSIST DEVICES
6.2.2.1 Ability to provide efficient cardiac support to drive the growth of this market segment
TABLE 12 PERCUTANEOUS VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
6.2.3 BIVENTRICULAR ASSIST DEVICES
6.2.3.1 Lack of reimbursement for BiVAD to restrict market growth to a certain extent
TABLE 13 BIVENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
6.2.4 RIGHT VENTRICULAR ASSIST DEVICES
6.2.4.1 RVADs are used as temporary cardiac assist devices
TABLE 14 RIGHT VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
6.3 INTRA-AORTIC BALLOON PUMPS
6.3.1 INCREASING RECALLS OF IABPS TO HINDER THE MARKET GROWTH
TABLE 15 RECENT IABP RECALLS IN THE HEART PUMP DEVICES MARKET
TABLE 16 INTRA-AORTIC BALLOON PUMPS MARKET, BY REGION, 2019-2026 (USD MILLION)
6.4 TOTAL ARTIFICIAL HEARTS
6.4.1 LAUNCH OF INNOVATIVE PRODUCTS TO ACCELERATE GROWTH IN THIS PRODUCT SEGMENT
TABLE 17 TOTAL ARTIFICIAL HEARTS MARKET, BY REGION, 2019-2026 (USD MILLION)
7 HEART PUMP DEVICES MARKET, BY TYPE (Page No. - 82)
7.1 INTRODUCTION
TABLE 18 HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
7.2 IMPLANTABLE HEART PUMP DEVICES
7.2.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GROWTH IN THIS MARKET SEGMENT
TABLE 19 IMPLANTABLE HEART PUMP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
7.3 EXTRACORPOREAL HEART PUMP DEVICES
7.3.1 EXTRACORPOREAL HEART PUMP DEVICES CAN BE USED IN PEDIATRIC PATIENTS—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 20 EXTRACORPOREAL HEART PUMP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
8 HEART PUMP DEVICES MARKET, BY THERAPY (Page No. - 86)
8.1 INTRODUCTION
TABLE 21 HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
8.2 BRIDGE-TO-TRANSPLANT (BTT)
8.2.1 GROWING NUMBER OF PATIENTS ON THE WAITING LIST TO SUPPORT MARKET GROWTH
TABLE 22 HEART PUMP DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT THERAPY, BY REGION, 2019-2026 (USD MILLION)
8.3 BRIDGE-TO-CANDIDACY (BTC)
8.3.1 EFFICIENT OUTCOMES PROVIDED BY BTC TO PROPEL MARKET GROWTH
TABLE 23 HEART PUMP DEVICES MARKET FOR BRIDGE-TO-CANDIDACY THERAPY, BY REGION, 2019-2026 (USD MILLION)
8.4 DESTINATION THERAPY (DT)
8.4.1 INTRODUCTION OF INNOVATIVE TECHNOLOGIES TO ACCELERATE SEGMENTAL GROWTH
TABLE 24 HEART PUMP DEVICES MARKET FOR DESTINATION THERAPY, BY REGION, 2019-2026 (USD MILLION)
8.5 OTHER THERAPIES
TABLE 25 HEART PUMP DEVICES MARKET FOR OTHER THERAPIES, BY REGION, 2019-2026 (USD MILLION)
9 HEART PUMP DEVICES MARKET, BY REGION (Page No. - 91)
9.1 INTRODUCTION
TABLE 26 HEART PUMP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
9.2 NORTH AMERICA
TABLE 27 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 28 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 29 NORTH AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 30 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 31 NORTH AMERICA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.2.1 US
9.2.1.1 Availability of reimbursements to support market growth
TABLE 32 CPT CODES FOR PROCEDURES RELATED TO VAD AND TAH
TABLE 33 US: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 34 US: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 35 US: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 36 US: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising incidence and prevalence of heart failure to propel market growth
TABLE 37 CANADA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 38 CANADA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 39 CANADA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 40 CANADA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.3 EUROPE
FIGURE 25 EUROPE: HEART PUMP DEVICES MARKET SNAPSHOT
TABLE 41 EUROPE: HEART PUMP DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 42 EUROPE: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 43 EUROPE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 44 EUROPE: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 45 EUROPE: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 High adoption of VADs as destination therapy in Germany to drive market growth
TABLE 46 GERMANY: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 47 GERMANY: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 48 GERMANY: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 49 GERMANY: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Long waiting list for heart transplants in the UK
TABLE 50 UK: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 51 UK: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 52 UK: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 53 UK: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Developments undertaken by local players to accelerate market growth in France
TABLE 54 FRANCE: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 55 FRANCE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 56 FRANCE: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 57 FRANCE: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Initiatives undertaken by local players to drive market growth in Italy
TABLE 58 ITALY: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 59 ITALY: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 60 ITALY: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 61 ITALY: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising geriatric population to propel market growth in Spain
TABLE 62 SPAIN: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 63 SPAIN: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 64 SPAIN: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 65 SPAIN: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 66 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050
TABLE 67 ROE: HEALTH EXPENDITURE (% OF GDP), 2010 VS. 2017
TABLE 68 ROE: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 69 ROE: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 70 ROE: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 71 ROE: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 26 ASIA PACIFIC: HEART PUMP DEVICES MARKET SNAPSHOT
TABLE 72 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 73 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 74 ASIA PACIFIC: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 75 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 76 ASIA PACIFIC: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Low rate of transplantations in the country to drive market growth
TABLE 77 JAPAN: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 78 JAPAN: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 79 JAPAN: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 80 JAPAN: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 High prevalence of CVDs in China to drive market growth
TABLE 81 CHINA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 82 CHINA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 83 CHINA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 84 CHINA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Huge target population in India to drive market growth
TABLE 85 INDIA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (US MILLION)
TABLE 86 INDIA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE,2019-2026 (USD MILLION)
TABLE 87 INDIA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 88 INDIA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Increasing prevalence of heart disease to accelerate market growth in Australia
TABLE 89 AUSTRALIA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 90 AUSTRALIA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 91 AUSTRALIA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 92 AUSTRALIA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 93 ROAPAC: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 94 ROAPAC: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 95 ROAPAC: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 96 ROAPAC: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 97 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 98 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 99 REST OF THE WORLD: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 100 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 101 REST OF THE WORLD: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.5.1 MIDDLE EAST & AFRICA
9.5.1.1 Increasing adoption of heart pump devices in the region to drive market growth
TABLE 102 MIDDLE EAST & AFRICA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 103 MIDDLE EAST & AFRICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 104 MIDDLE EAST & AFRICA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
9.5.2 LATIN AMERICA
9.5.2.1 Rising geriatric population to increase the demand for heart pump devices in the region
TABLE 106 LATIN AMERICA: HEART PUMP DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 107 LATIN AMERICA: VENTRICULAR ASSIST DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 108 LATIN AMERICA: HEART PUMP DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 109 LATIN AMERICA: HEART PUMP DEVICES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 132)
10.1 OVERVIEW
FIGURE 27 KEY DEVELOPMENTS IN THE HEART PUMP DEVICES MARKET, JANUARY 2018-APRIL 2021
FIGURE 28 MARKET EVOLUTION MATRIX: JANUARY 2018 TO APRIL 2021
10.2 REVENUE ANALYSIS
10.2.1 HEART PUMP DEVICES MARKET: REVENUE ANALYSIS OF THE TOP 5 MARKET PLAYERS
FIGURE 29 TOP 5 PLAYERS HAVE DOMINATED THE MARKET IN THE LAST 3 YEARS
10.3 MARKET SHARE ANALYSIS
TABLE 110 HEART PUMP DEVICES MARKET: DEGREE OF COMPETITION
10.4 COMPANY EVALUATION MATRIX
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 30 VENDOR DIVE: HEART PUMP DEVICES MARKET
10.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 STARTING BLOCKS
10.5.3 RESPONSIVE COMPANIES
10.5.4 DYNAMIC COMPANIES
FIGURE 31 HEART PUMP DEVICES MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020
10.6 COMPETITIVE SCENARIO
10.6.1 PRODUCT APPROVALS
TABLE 111 KEY PRODUCT APPROVALS, JANUARY 2018-APRIL 2021
10.6.2 DEALS
TABLE 112 KEY DEALS, JANUARY 2018-APRIL 2021
10.6.3 OTHER DEVELOPMENTS
TABLE 113 OTHER KEY DEVELOPMENTS, JANUARY 2018-APRIL 2021
10.7 COMPANY FOOTPRINT
TABLE 114 COMPANY FOOTPRINT
TABLE 115 COMPANY PRODUCT FOOTPRINT
TABLE 116 COMPANY TYPE FOOTPRINT
TABLE 117 COMPANY GEOGRAPHICAL FOOTPRINT
11 COMPANY PROFILES (Page No. - 144)
11.1 KEY PLAYERS
(Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)*
11.1.1 ABBOTT LABORATORIES
TABLE 118 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.2 ABIOMED
TABLE 119 ABIOMED: BUSINESS OVERVIEW
FIGURE 33 ABIOMED: COMPANY SNAPSHOT (2020)
11.1.3 MEDTRONIC
TABLE 120 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT (2020)
11.1.4 TELEFLEX INCORPORATED
TABLE 121 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
FIGURE 35 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020)
11.1.5 SYNCARDIA SYSTEMS
TABLE 122 SYNCARDIA SYSTEMS: BUSINESS OVERVIEW
11.1.6 FRESENIUS MEDICAL CARE AG & CO. KGAA
TABLE 123 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW
FIGURE 36 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2020)
11.1.7 CARDIACASSIST, INC.
TABLE 124 CARDIACASSIST, INC.: BUSINESS OVERVIEW
FIGURE 37 LIVANOVA PLC: COMPANY SNAPSHOT (2020)
11.1.8 GETINGE
TABLE 125 GETINGE: BUSINESS OVERVIEW
FIGURE 38 GETINGE: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 BERLIN HEART
TABLE 126 BERLIN HEART: BUSINESS OVERVIEW
11.2.2 JARVIK HEART, INC.
TABLE 127 JARVIK HEART, INC.: BUSINESS OVERVIEW
11.2.3 CARMAT
TABLE 128 CARMAT: BUSINESS OVERVIEW
11.2.4 SENKO MEDICAL INSTRUMENT MFG. CO., LTD.
TABLE 129 MERA: BUSINESS OVERVIEW
11.2.5 ANGIODROID
TABLE 130 ANGIODROID: BUSINESS OVERVIEW
11.2.6 CARDIODYME
TABLE 131 CARDIODYME: BUSINESS OVERVIEW
11.2.7 WORLD HEART CORPORATION
TABLE 132 WORLD HEART CORPORATION: BUSINESS OVERVIEW
*Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 171)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
